Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Folate
Selected research topic
Migraine and pain
Confirmed comparison evidence for this topic is limited. The findings below retain their study conditions.
Findings from a combination study cannot be attributed to this ingredient alone.
- Publications for this topic
- 1
- Human comparison publications
- 0
- Publications needing review
- 0
Findings in the studies
migraine with aura (MA) in adults
Research with unclear study subject or type
- Results for this measurement were mixed; no consistent conclusion can be drawn.
Several ingredients were tested together, so this ingredient’s individual effect is unknown.
Combination studyMeasurement and study conditions
- Study type
- Systematic review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Ingredient combination
- How results were compared
- Results were compared between groups. · Study comparison: B6 alone or B6 with folate and/or B12 vs placebo; folate alone vs placebo
- Measurement time
- Not confirmed.
Representative outcome and study details
Studies with an unspecified organism reported mixed results for migraine with aura (MA) in adults.
combination-ingredient studies · Individual ingredient effects cannot be separated · Includes patient groups · between-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
- Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: B
The 58.7 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 94
Papers linked to this topic 1 · distinct papers 1 · comparison findings need further review · papers needing additional review 0
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- migraine with aura (MA) in adults: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
migraine with aura (MA) in adults
Results for this measurement were mixed; no consistent conclusion can be drawn.
Review · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No reviewed caution rules are available yet. Reported caution findings are shown below.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Cautions reported with another supplement or medication
These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.
Sodium ValproateValproate interferes with one-carbon metabolism and folate transport, potentially reducing folic acid efficacy and increasing congenital risks.